Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Magnitude Bioresorbable Scaffold Shows Low MACE, Restenosis Rates at Nine Months
News | Stents Bioresorbable | October 01, 2018
Magnitude Bioresorbable Scaffold Shows Low MACE, Restenosis Rates at Nine Months

October 1, 2018 — New results from the RENASCENT studies presented at the Transcatheter Cardiovascular Therapeutics...
read more
Videos | Hemodynamic Support Devices | October 01, 2018
VIDEO: The Importance of Ventricular Unloading in AMI and Cardiogenic Shock

Nevin Kapur, M.D.,...
read more
Mitral Regurgitation Volume Reduced at One Year in REDUCE FMR Trial
News | Heart Failure | September 28, 2018
Mitral Regurgitation Volume Reduced at One Year in REDUCE FMR Trial

September 28, 2018 — Heart failure...
read more
Portico Transcatheter Aortic Valve Successfully Reduces Severe Aortic Stenosis at One Year
News | Heart Valve Technology | September 28, 2018
Portico Transcatheter Aortic Valve Successfully Reduces Severe Aortic Stenosis at One Year

September 28, 2018 — At one year following...
read more
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients

September 28, 2018 — The first randomized study to compare general versus local anesthesia during...
read more
Videos | Hemostasis Management | September 27, 2018
VIDEO: How to Achieve Hemostasis With Large Bore Device Access

Philippe Genereux...
read more
FDA Approves Biotronik's PK Papyrus Stent for Coronary Perforations
Technology | Stents | September 27, 2018
FDA Approves Biotronik's PK Papyrus Stent for Coronary Perforations

September 27, 2018 — Biotronik recently announced U.S. Food and Drug Administration (FDA) approval of the PK Papyrus...
read more
Videos | Heart Failure | September 26, 2018
VIDEO: MitraClip to Treat Heart Failure - Results of the COAPT Trial

William Abraham,...
read more
Videos | Intravascular Imaging | September 26, 2018
VIDEO: Near Infrared Spectroscopy Detects, Aids Risk Assessment of Vulnerable Plaques

Ron Waksman, M.D., associate...
read more
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation

September 26, 2018 — Patients with ...
read more
Eluvia Drug-Eluting Stent Demonstrates Superior Patency in IMPERIAL Trial
News | Stents Drug Eluting | September 26, 2018
Eluvia Drug-Eluting Stent Demonstrates Superior Patency in IMPERIAL Trial

September 26, 2018 — Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018...
read more
NIRS-IVUS Detects Patients and Plaques Vulnerable to Subsequent Adverse Coronary Events
News | Intravascular Imaging | September 25, 2018
NIRS-IVUS Detects Patients and Plaques Vulnerable to Subsequent Adverse Coronary Events

September 25, 2018 – New data demonstrate the correlation between the presence of non-flow-limiting, non-intervened-...
read more
Virtue Sirolimus-Eluting Balloon Demonstrates Positive Safety and Efficacy at Three Years
News | Drug-Eluting Balloons | September 25, 2018
Virtue Sirolimus-Eluting Balloon Demonstrates Positive Safety and Efficacy at Three Years

September 25, 2018 — Orchestra BioMed Inc. announced the three-year clinical results from its Sirolimus Angioplasty...
read more
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure

September 24, 2018 — Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S....
read more
Three-Year Real-World Data Support In.Pact Admiral as Primary PAD Therapy
News | Drug-Eluting Balloons | September 24, 2018
Three-Year Real-World Data Support In.Pact Admiral as Primary PAD Therapy

September 24, 2018 — New data announced at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept...
read more
© Copyright Scranton Gillette Communications. All Rights Reserved.
Overlay Init